Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research Platforms

Sponsor
The University of Hong Kong
Study ID
NCT07570667
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
40 Years - 70 Years
Healthy Volunteers
Accepted

Study Details

The investigators propose a prospective, longitudinal, observational study to improve health assessment by analyzing blood plasma molecular patterns in each individual over time using artificial intelligence (AI) to identify key measurements for early detection of NCDs. It will develop personalized reference ranges and screening methods, laying the foundation for population-based early detection. This study focus on collecting health data and biospecimen samples to understand early molecular changes linked to disease.

Key Dates

First listed
May 6, 2026
Start date
May 1, 2026
Status verified
Apr 2026
Primary completion
May 29, 2048
Completion
May 29, 2048

Study Design

Enrollment
15,000 participants (estimated)

Arms

  • Arm: Low-risk arm
    a cohort of 7,500 participants with the absence of modifiable cardiovascular risk factors, who are at low risk of contracting selected NCDs
  • Arm: High-risk arm
    a cohort of 7,500 participants with the presence of cardiovascular risk factors, who are at high risk of contracting selected NCDs

Primary Outcome Measure

Establish Personalized Molecular Baselines [ Time Frame: 10 years ]

Central Contacts

Find similar trials

Related Studies